Recombinant Factor VIIa: A Viewpoint by Amy D. Shapiro

By Shapiro A.D.  

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 78-79

Adis International

Access to resources Recommend Favorite

Hepatic capsule haemorrhage due to HELLP syndrome managed with recombinant factor VIIa

By Gandhimathi K   McLornan D   O'Neill F  

Clinical Intensive Care, Vol. 15, Iss. 1, 2004-03 ,pp. : 15-18

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders

By Croom Katherine F.   McCormack Paul L.  

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 121-136

Adis International

Access to resources Recommend Favorite

Regional Administration of Recombinant Tumour Necrosis Factor- in Cancer, with Special Reference to Melanoma

By Lejeune F.  

BioDrugs, Vol. 9, Iss. 3, 1998-03 ,pp. : 211-218

Adis International

Access to resources Recommend Favorite

The role of activated recombinant factor VII (rFVIIa) in acute severe bleeding

By Raobaikady R   Grounds RM  

Clinical Intensive Care, Vol. 15, Iss. 4, 2004-12 ,pp. : 115-117

Ashgate Publishing Ltd

Access to resources Recommend Favorite